硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 RNASEH2C 抗体对
试剂盒

人 RNASEH2C 抗体对

01AB02890

Ribonuclease H2 subunit C (RNASEH2C) is the non-catalytic component of the heterotrimeric RNase H2 complex, which degrades RNA:DNA hybrids and removes misincorporated ribonucleotides to maintain genomic stability. Structurally, RNASEH2C is integral to the formation of the complex's triple beta-barrel core, ensuring the stability and enzymatic activity of the catalytic subunit. Biallelic loss-of-function mutations in RNASEH2C cause Aicardi-Goutières syndrome type 3 (AGS3), an autoinflammatory encephalopathy characterized by severe neurological dysfunction, intracranial calcifications, and leukodystrophy. These defects lead to the accumulation of endogenous nucleic acids, triggering aberrant type I interferon-mediated immune responses.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
RNASEH2C
基因别名
AYP1
蛋白别名
ribonuclease H2 subunit C; RNASEH2C
UniProt
Q8TDP1
物种
Human

产品详情

靶点名称
RNASEH2C
蛋白名称
ribonuclease H2 subunit C
蛋白别名
Ribonuclease H2 subunit C; RNase H2 subunit C; Aicardi-Goutieres syndrome 3 protein; AGS3; RNase H1 small subunit; Ribonuclease HI subunit C
靶点基因名
RNASEH2C
基因别名
AYP1
UniProt
Q8TDP1
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Ribonuclease H2 subunit C (RNASEH2C) is the non-catalytic component of the heterotrimeric RNase H2 complex, which degrades RNA:DNA hybrids and removes misincorporated ribonucleotides to maintain genomic stability. Structurally, RNASEH2C is integral to the formation of the complex's triple beta-barrel core, ensuring the stability and enzymatic activity of the catalytic subunit. Biallelic loss-of-function mutations in RNASEH2C cause Aicardi-Goutières syndrome type 3 (AGS3), an autoinflammatory encephalopathy characterized by severe neurological dysfunction, intracranial calcifications, and leukodystrophy. These defects lead to the accumulation of endogenous nucleic acids, triggering aberrant type I interferon-mediated immune responses.